"Prothrombin/pharmacology"[MAJR] - Search Results

Year	Number of Results
1947	1
1948	1
1959	3
1960	2
1962	2
1966	2
1967	2
1968	2
1969	7
1970	1
1971	3
1972	1
1973	2
1974	4
1975	6
1976	6
1977	1
1978	4
1979	4
1980	3
1981	10
1982	3
1983	1
1985	2
1986	2
1987	1
1988	6
1989	1
1990	4
1991	5
1992	4
1993	2
1994	2
1995	5
1996	3
1997	2
1998	5
1999	9
2000	2
2001	3
2002	6
2003	4
2004	5
2005	7
2006	10
2007	7
2008	6
2009	5
2010	3
2011	8
2012	9
2013	8
2014	14
2015	12
2016	7
2017	1
2018	2
2019	9
2020	3
2021	1
2024	0

1

Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis.

Nederpelt CJ, Naar L, Krijnen P, le Cessie S, Kaafarani HMA, Huisman MV, Velmahos GC, Schipper IB. Nederpelt CJ, et al. Crit Care Med. 2021 Oct 1;49(10):e1025-e1036. doi: 10.1097/CCM.0000000000005059. Crit Care Med. 2021. PMID: 33967205

2

Oral IIa inhibitors.

Lee CJ, Badhwar G, Ansell JE. Lee CJ, et al. Hematol Oncol Clin North Am. 2010 Aug;24(4):739-53, ix. doi: 10.1016/j.hoc.2010.05.001. Hematol Oncol Clin North Am. 2010. PMID: 20659658 Review.

3

New anticoagulants: pharmacology and clinical studies.

Samama CM. Samama CM. Wien Med Wochenschr. 2011 Feb;161(3-4):54-7. doi: 10.1007/s10354-011-0875-9. Wien Med Wochenschr. 2011. PMID: 21404139 Review.

4

Thrombogenicity of prothrombin complex concentrates.

Köhler M. Köhler M. Thromb Res. 1999 Aug 15;95(4 Suppl 1):S13-7. doi: 10.1016/s0049-3848(99)00079-1. Thromb Res. 1999. PMID: 10499904 Review.

5

Monitoring of direct anticoagulants.

Lison S, Spannagl M. Lison S, et al. Wien Med Wochenschr. 2011 Feb;161(3-4):58-62. doi: 10.1007/s10354-011-0876-8. Wien Med Wochenschr. 2011. PMID: 21404140 Review.

6

[Reversal strategies for non-vitamin K antagonist oral anticoagulants].

Larsen FU, Hvas AM, Grove EL. Larsen FU, et al. Ugeskr Laeger. 2016 Oct 3;178(40):V03160212. Ugeskr Laeger. 2016. PMID: 27697119 Free article. Review. Danish.

7

Snake venom prothrombin activators similar to blood coagulation factor Xa.

Joseph JS, Kini RM. Joseph JS, et al. Curr Drug Targets Cardiovasc Haematol Disord. 2004 Dec;4(4):397-416. doi: 10.2174/1568006043335781. Curr Drug Targets Cardiovasc Haematol Disord. 2004. PMID: 15578960 Review.

8

Indications for prothrombin complex concentrates in massive transfusions.

Blauhut B. Blauhut B. Thromb Res. 1999 Aug 15;95(4 Suppl 1):S63-9. doi: 10.1016/s0049-3848(99)00086-9. Thromb Res. 1999. PMID: 10499911 Review.

9

Non-vitamin K oral anticoagulants (NOAC) and the risk of myocardial infarction: Differences between factor IIa and factor Xa inhibition?

Polzin A, Dannenberg L, Wolff G, Helten C, Achilles A, Hohlfeld T, Zeus T, Kelm M, Massberg S, Petzold T. Polzin A, et al. Pharmacol Ther. 2019 Mar;195:1-4. doi: 10.1016/j.pharmthera.2018.10.005. Epub 2018 Oct 12. Pharmacol Ther. 2019. PMID: 30321554 Review.

10

A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.

Khorsand N, Kooistra HA, van Hest RM, Veeger NJ, Meijer K. Khorsand N, et al. Thromb Res. 2015 Jan;135(1):9-19. doi: 10.1016/j.thromres.2014.11.019. Epub 2014 Nov 22. Thromb Res. 2015. PMID: 25480313 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

241 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year